Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported annual fiscal-period values; no daily interpolation.
PEG RATIO
N/A
PEG RATIO AVG TTM
N/A
PEG RATIO AVG 3Y
0.07
PEG RATIO AVG 5Y
0.12
PEG RATIO AVG 10Y
N/A
PEG RATIO AVG 15Y
N/A
PEG RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$10.37B
PEG Ratio
N/A
TTM Avg
0.05
3Y Avg
0.05
5Y Avg
0.14
Market Cap
$10.39B
PEG Ratio
0.26
TTM Avg
0.21
3Y Avg
0.54
5Y Avg
0.70
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oscar Health, Inc. (OSCR) | $7.81B | N/A | N/A | 0.07 | 0.12 |
| Tempus AI, Inc. (TEM)vs › | $8.18B | N/A | 0.60 | 1.25 | 1.25 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.06B | N/A | 0.84 | 0.69 | 0.69 |
| Insulet Corp. (PODD)vs › | $9.23B | 0.39 | 0.23 | 2.94 | 3.14 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.36B | N/A | 0.10 | 0.17 | 0.14 |
| Molina Healthcare, Inc. (MOH)vs › | $10.19B | N/A | 1.00 | 1.06 | 1.04 |
| Henry Schein, Inc. (HSIC)vs › | $10.21B | 3.23 | 3.23 | 3.23 | 1.76 |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | N/A | 0.05 | 0.05 | 0.14 |
| Universal Health Services, Inc. (UHS)vs › | $10.39B | 0.26 | 0.21 | 0.54 | 0.70 |
| Bio-Techne Corporation (TECH)vs › | $11.27B | N/A | 5.16 | 3.55 | 2.84 |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PEG RATIO |
|---|---|
| 2025-12-31 | 0.01 |
| 2023-12-31 | 0.13 |
| 2022-12-31 | 0.08 |
| 2020-12-31 | 0.25 |
